CGEM - Cullinan Oncology Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2026-02-10)
Last
 12.19		 Change
 ⇑ +0.36   (+3.04%)		 Volume
  513,782
Open
 12.08		 High
 12.55		 Low
 11.83
8EMA (Daily)
 12.14		 40EMA (Daily)
 11.29		 50EMA (Daily)
 11.03		 STO (Daily)
 49.035		 MACD Hist (Daily)
 -0.104
8EMA (Weekly)
 11.504		 40EMA (Weekly)
 9.82		 50EMA (Weekly)
 9.93		 STO (Weekly)
 77.444		 MACD Hist (Weekly)
 0.138
Company Profile
Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2026 OptionChance.com